In the journals: B vitamins may protect against macular degeneration
In the journals
612After an average of 7.3 years, there were 55 cases of AMD among the women taking the supplement and 82 cases among those taking a placebo, a 34% difference. For visually significant (or worsening) AMD, there were 26 cases in the supplement group and 44 in the placebo group, a 41% difference. The advantage for the folic acid/B vitamin treatment began to emerge in the first two years of the study.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online Plus (HHO+) to unlock expert-backed health insights, personalized tools, and exclusive resources to feel your best every day.
Here’s what you get with your HHO+ membership:
- Unlimited access to all Harvard Health Online content
- 4 expertly curated newsletters delivered monthly
- Customized website experience aligned to your health goals
- In-depth health guides on topics like sleep, exercise, and more
- Interactive features like videos and quizzes
- Members-only access to exclusive articles and resources
I’d like to subscribe to HHO+ for $4.99/month to access expert-backed content to help make smart, informed decisions about my well-being.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
